Código QR (código de barras bidimensional)

A rapid in vivo screen for pancreatic ductal adenocarcinoma therapeutics

Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer-related deaths in the United States, and is projected to be second by 2025. It has the worst survival rate among all major cancers. Two pressing needs for extending life expectancy of affected individuals are the developmen...

ver descrição completa

Na minha lista:
Principais autores: Ozhan Ocal, Victor Pashkov, Rahul K. Kollipara, Yalda Zolghadri, Victoria H. Cruz, Michael A. Hale, Blake R. Heath, Alex B. Artyukhin, Alana L. Christie, Pantelis Tsoulfas, James B. Lorens, Galvin H. Swift, Rolf A. Brekken, Thomas M. Wilkie
Formato: Artigo
Idioma:Inglês
Publicado em: The Company of Biologists 2015-10-01
coleção:Disease Models & Mechanisms
Assuntos:
Rgs16::GFP reporter
Kras
Rapid in vivo screen
Pancreatic cancer combination therapy
Gas6
Axl
Warfarin
Gemcitabine
Abraxane
Acesso em linha:http://dmm.biologists.org/content/8/10/1201
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados